Treatment of Pediatric Glioblastoma with Combination Olaparib and Temozolomide Demonstrates 2‐Year Durable Response

For pediatric patients with high‐grade gliomas, standard‐of‐care treatment includes surgery, chemotherapy, and radiation therapy; however, most patients ultimately succumb to their disease. With advances in genomic characterization of pediatric high‐grade gliomas, the use of targeted therapies in co...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncologist
Autori principali: Valiakhmetova, Andge, Gorelyshev, Sergey, Konovalov, Alexander, Trunin, Yuri, Savateev, Alexander, Kram, David E., Severson, Eric, Hemmerich, Amanda, Edgerly, Claire, Duncan, Daniel, Britt, Nicholas, Huang, Richard S.P., Elvin, Julia, Miller, Vincent, Ross, Jeffrey S., Gay, Laurie, McCorkle, Joshua, Rankin, Andrew, Erlich, Rachel L., Chudnovsky, Yakov, Ramkissoon, Shakti H.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley & Sons, Inc. 2019
Soggetti:
Precision Medicine Clinic: Molecular Tumor Board
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7011619/
https://ncbi.nlm.nih.gov/pubmed/32043779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2019-0603
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi